Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:337-343
Published online before print December 24, 2008, doi: 10.1161/STROKEAHA.108.518878
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/2/337    most recent
STROKEAHA.108.518878v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qiao, Q.
Right arrow Articles by Tuomilehto, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qiao, Q.
Right arrow Articles by Tuomilehto, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
Medline Plus Health Information
*Metabolic Syndrome
*Stroke
Related Collections
Right arrow Type 2 diabetes
Right arrow Glucose intolerance
Right arrow Acute myocardial infarction
Right arrow Acute Cerebral Hemorrhage
Right arrow Acute Cerebral Infarction
Right arrow Epidemiology

(Stroke. 2009;40:337.)
© 2009 American Heart Association, Inc.


Original Contributions

Comparison of Definitions of Metabolic Syndrome in Relation to the Risk of Developing Stroke and Coronary Heart Disease in Finnish and Swedish Cohorts

Qing Qiao, MD, PhD; Tiina Laatikainen, MD, PhD; Björn Zethelius, MD, PhD; Birgitta Stegmayr, MD, PhD; Mats Eliasson, MD, PhD; Pekka Jousilahti, MD, PhD Jaakko Tuomilehto, MD, PhD

From the Department of Public Health (Q.Q., J.T.), University of Helsinki, Helsinki, Finland; the Department of Health Promotion and Chronic Disease Prevention (Q.Q., T.L., P.J., J.T.), National Public Health Institute, Helsinki, Finland; the Department of Public Health/Geriatrics (B.Z.), Uppsala University Hospital, Uppsala, Sweden; and the Department of Public Health and Clinical Medicine (B.S., M.E.), University of Umeå, Umeå, Sweden.

Correspondence to Qing Qiao, MD, PhD, Department of Public Health, University of Helsinki, PL41, Mannerheimintie 172, FIN-00014 Helsinki, Finland. E-mail qing.qiao{at}ktl.fi

Background and Purpose— The purpose of this study was to compare definitions of metabolic syndrome with regard to their prediction of stroke and coronary heart disease incidence.

Methods— The study comprises 4041 men and 3812 women of 6 Finnish and Swedish cohorts aged 25 to 74 years at baseline. Hazard ratio was estimated applying Cox regression analyses adjusting for cohort, cholesterol, and smoking and using age as a time scale. A paired homogeneity test was performed to compare the differences.

Results— A total of 113 (47) ischemic and 43 (15) hemorrhagic stroke and 235 (50) coronary heart disease events were accumulated in men (women). Hazard ratios (95% CIs) for ischemic stroke in men were 1.59 (1.09 to 2.32), 1.52 (1.01 to 2.28), 1.16 (0.77 to 1.74), and 1.27 (0.87 to 1.86), respectively, for the World Health Organization, National Cholesterol Education Program, National Cholesterol Education Program revised, and the International Diabetes Federation definitions of metabolic syndrome, and in women 2.20 (1.15 to 4.19), 2.68 (1.47 to 4.87), 2.31 (1.27 to 4.20), and 1.91 (1.05 to 3.49), respectively. The corresponding hazard ratios (95% CIs) for coronary heart disease were 1.57 (1.21 to 2.04), 1.51 (1.15 to 1.99), 1.63 (1.25 to 2.13), and 1.46 (1.12 to 1.89) in men and 1.32 (0.69 to 2.51), 1.54 (0.85 to 2.79), 1.81 (1.02 to 3.21), and 2.47 (1.37 to 4.45) in women. None of the definitions of metabolic syndrome predicted hemorrhagic stroke. There was no difference between definitions of metabolic syndrome and between a full definition and its individual components.

Conclusions— Metabolic syndrome as well as its individual components predicted the incidence of the ischemic stroke and the coronary heart disease equally well and should be treated equally as well.


Key Words: metabolic syndrome • stroke • coronary heart disease • definitions